טוען...
Conditional approval of cancer drugs in Canada: accountability and impact on public funding
BACKGROUND: We examined how conditional market approval of cancer pharmaceuticals by Health Canada (hc) affects public funding recommendations by the pan-Canadian Oncology Review (pcodr). We were also interested to see how often hc conditions are enforced. METHODS: Health Canada and pcodr databases...
שמור ב:
| הוצא לאור ב: | Curr Oncol |
|---|---|
| Main Authors: | , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Multimed Inc.
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6380633/ https://ncbi.nlm.nih.gov/pubmed/30853815 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.26.4397 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|